Literature DB >> 680500

Phalloidin-induced cholestasis in the rat: relation to changes in microfilaments.

M Dubin, M Maurice, G Feldmann, S Erlinger.   

Abstract

The influence of phalloidin, an agent that causes irreversible polymerisation of actin into microfilaments, on bile secretion and hepatocyte ultrastructure was examined in rats. Phalloidin was given intraperitoneally at the dose of 50 microgram per 100 g of body weight per day for 1, 3, or 7 days. The following was observed. (1) Bile flow decreased, as compared to controls, by 19% after 1 day, 34% after 3 days, and 55% after 7 days. Bile acid secretion was also decreased. (2) Electron microscopic examination of the hepatocyte in treated animals revealed an increased thickness of the pericanalicular microfilamentous network and a dilatation of bile canaliculi. Stereological examination revealed an increase in the relative volume of the microfilamentous network (per unit of hepatocyte cytoplasm) of 2.55% after 1 day, 4.06% ater 3 days, and 6.16% after 7 days. (3) [14C]Erythritol biliary clearance, measured after 7 days, decreased in parallel to bile flow, suggesting that the decrease in bile flow was of canalicular origin. [14C]Sucrose biliary clearance increased in treated animals, suggesting an increased permeability of the biliary system to sucrose. There was a predominant decrease in the bile acid independent bile flow. These data provide circumstantial evidence for the hypothesis that microfilament dysfunction can produce cholestasis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680500

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.

Authors:  G Abdel-Aziz; G Lebeau; P Y Rescan; B Clément; M Rissel; Y Deugnier; J P Campion; A Guillouzo
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trial.

Authors:  Y Fukumoto; K Okita; T Kodama; S Matsuda; S Kawamura; K Harima; Y Harada; K Kawaguchi; Y Iida; T Konishi; K Andoh; H Tanaka; T Hanta; T Sekitani; T Takenami; T Yamasaki; S Yamashita; H Fujimura; M Shimada; M Kohzu; K Shigeta; H Shirasawa
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Intermediate filaments of hepatocytes and biliary epithelial cells in bile duct obstruction: transmission and scanning electron microscopy study.

Authors:  T Okanoue; M Ohta; K Kachi; Y Ohta; Y Sawa; H Kanaoka; K Kagawa; T Takino; S W French
Journal:  Gastroenterol Jpn       Date:  1988-08

4.  Effects of phalloidin and cytochalasin B on cytoskeletal structures in cultured rat hepatocytes.

Authors:  I Nickola; M Frimmer
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

5.  "Varicoid change" of bile canaliculi in rat liver at an early phase of ischaemia-reperfusion injury.

Authors:  H Yasui; T Takamatsu; S Fujita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Microfilaments around the bile canaliculi in patients with intrahepatic cholestasis.

Authors:  H Imanari; H Kuroda; K Tamura
Journal:  Gastroenterol Jpn       Date:  1981

Review 7.  The role of cytoskeletal and cytocontractile elements in pathologic processes.

Authors:  E Rungger-Brändle; G Gabbiani
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

8.  Fetal Niemann-Pick disease type C: ultrastructural and lipid findings in liver and spleen.

Authors:  C Dumontel; C Girod; F Dijoud; Y Dumez; M T Vanier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Intrahepatic cholestasis and hyperbilirubinemia in ethynyl estradiol and chlorpromazine-treated rats.

Authors:  T Obata
Journal:  Gastroenterol Jpn       Date:  1983-12

10.  Competitive inhibition of the uptake of demethylphalloin by cholic acid in isolated hepatocytes. Evidence for a transport competition rather than a binding competition.

Authors:  E Petzinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.